Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

By Van Cutsem Eric  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 223-225

Springer Publishing Company

Access to resources Recommend Favorite

Should Patients with Advanced Colorectal Cancer be Treated with Chemotherapy?

By Blijham G.H.   Labianca R.   Bleiberg H.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 815-824

Elsevier

Access to resources Recommend Favorite

Survival of untreated advanced colorectal cancer patients

By  

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 731-733

Spandidos Publications

Access to resources Recommend Favorite

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

and polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection

By Chae Yee   Kim Jong   Sohn Sang   Lee Su   Kang Byung   Moon Joon   Park Jae   Jeon Seong   Bae Han-Ik   Choi Gyu   Jun Soo-Han  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 705-713

Springer Publishing Company

Access to resources Recommend Favorite